Cargando…
Epigenetic Regulation of the Non-Coding Genome: Opportunities for Immuno-Oncology
The contribution of the non-coding genome to disease and its therapeutic potential have been largely unexplored. Recently, several epigenetic drugs developed for cancer treatment have been described to mediate therapeutic effects through the reactivation of the expression of transposable elements in...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594693/ https://www.ncbi.nlm.nih.gov/pubmed/34968293 http://dx.doi.org/10.3390/epigenomes4030022 |